Definiens Partners in Life Sciences

Beecher Instruments is a scientific engineering company that has pioneered the development of tissue micro array (TMA) instrumentation. Beecher is continuously improving tissue micro array technology and developing new approaches for automated, high-throughput translational research. Beecher is currently building image analysis routines using Definiens Cognition Network software and coupling these applications with Beecher’s TMA technology to develop integrated TMA analysis solutions.

Bioscan, Inc. is a developer and supplier of advanced molecular imaging tools for pre-clinical and biomedical research applications. Over the last two years, the company has introduced nuclear imagers with sub-mm image resolution capabilities. Developed in collaboration with Mediso Ltd of Budapest, Hungary, Bioscan’s single-photon computed tomography (SPECT) and positron emission tomography (PET) systems are the first systems that can image small animals with the same visual acuity as can be obtained from scanning humans. In addition to these dual-modality NanoPET/CT® and NanoSPECT/CT® systems, Bioscan supplies supporting radiotracer synthesis and biotracer quality control equipment allowing researchers in pharmaceutical companies and biomedical research institutes to conduct translational research and speed up the development of new therapies. Bioscan is headquartered in Washington, DC and has offices in Europe and distributors worldwide.

Carl Zeiss MicroImaging GmbH is the leading supplier of non-contact laser microdissection and micromanipulation systems. These systems stand for absolute sample purity and assure contamination-free scientific work. They are based on the successful PALM MicroBeam modular design, permitting gentle isolation of biomolecules and living cell material through non-contact LCM (Laser Capture Microdissection), as well as the use of an optical trap. The trap is based on the optical tweezers technology for micro-level manipulation and sorting of material. Both modules can be used individually or together in the PALM CombiSystem, thus providing ideal working conditions as a research platform – even for complex applications. The integration of high content image analysis into automated sample harvesting provides quick and reliable characterization of the material of interest for subsequent analysis with simultaneous significant saving of time.

CTC Laboratory Systems Corporation (Tokyo, Japan), a group company of ITOCHU Corporation, is Japan's leading provider of total information technology solutions for pharmaceutical, chemical, and food processing industries, as well as life sciences research institutions.

Hamamatsu Photonics is a world-leading manufacturer of opto-electronic components and systems and employs over 3000 staff worldwide. The corporate headquarters are based in Hamamatsu City, Japan along with six manufacturing plants and central research laboratories. Since its inception in 1953, Hamamatsu Photonics has expanded to now enjoy a global presence with production facilities, business locations and associated companies throughout Asia, Europe and North America.

Hamamatsu Photonics’ corporate philosophy stresses the advancement of Photonics through extensive research and development. The component- and system-products such as photosensors, cameras, complex systems are widely used in different research fields like communication, biomedical science, material science, pharmacology, medical science and many others.

S.CO LifeScience develops and markets high-quality solutions for all questions in image analysis, with a strong focus on life sciences. The integration of the revolutionary Cognition Network Technology of Definiens guarantees an extraordinarily robust and differentiated recognition of objects. The system is operated via the innovative web-based user interface S.CORE, which only requires a common internet browser without any additional software installation.

For over 25 years Tessella has worked with some of the biggest names in the pharmaceutical industry. We help clients address a wide range of business goals, including, improving efficiency and productivity in drug discovery, delivering the business benefits of translational medicine, and faster more effective clinical trials. What makes our technology and consulting services effective is our understanding of both the science and informatics of pharmaceutical R&D, as well as unique software assets and intellectual property that reduce project risk, cost and time. With offices in Europe and North America, global companies rely on Tessella for business critical assignments.